New screening method for common heart disorder
<p>A team of Egyptian cardiologists has discovered a simple new way of diagnosing the world’s most common genetically transmitted heart disorder and identifying affected patients who have an increased risk of adverse cardiovascular events . Hypertrophic cardiomyopathy (HCM) affects approximate...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| منشور في: |
2015
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513559545774080 |
|---|---|
| author | Nature Research (16552612) |
| author_facet | Nature Research (16552612) |
| author_role | author |
| dc.creator.none.fl_str_mv | Nature Research (16552612) |
| dc.date.none.fl_str_mv | 2015-04-30T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.57945/manara.23910165.v1 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/online_resource/New_screening_method_for_common_heart_disorder/23910165 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Cardiology heart disorder treadmill testing Hypertrophic cardiomyopathy |
| dc.title.none.fl_str_mv | New screening method for common heart disorder |
| dc.type.none.fl_str_mv | Text Online resource info:eu-repo/semantics/publishedVersion text |
| description | <p>A team of Egyptian cardiologists has discovered a simple new way of diagnosing the world’s most common genetically transmitted heart disorder and identifying affected patients who have an increased risk of adverse cardiovascular events . Hypertrophic cardiomyopathy (HCM) affects approximately 1 in 500 people and is characterised primarily by abnormal thickening of the heart’s muscle tissue, which makes it harder for the heart to pump blood around the body. One common complication of the condition is obstruction of the left ventricular outflow tract (LVOT), in which the volume of blood pumped around the body is dramatically reduced. LVOT obstruction can occur under stress and during exercise, when contractility of the left ventricle increases. It leads to progression of hypertrophic cardiomyopathy, and predicts adverse outcomes such as cardiac arrest and sudden death in HCM patients. Over 30 percent of patients who have non-obstructive cardiomyopathy do end up with obstruction under stress or exercise. Clinicians can provoke LVOT obstruction in patients by exercise treadmill testing, in order to screen for and diagnose HCM, and to predict future complications, but this is not possible in those who are not able to do exercise for any reason. Hala Mahfouz Badran of Menoufiya University and her colleagues studied 39 HCM patients. They used echocardiography to measure the patients’ heart activity at rest, then compared exercise and an under-the-tongue spray of isosorbide dinitrate (ISDN) — which is used to treat angina — in their ability to induce and evaluate LVOT obstruction. They found that ISDN inhalation provokes LVOT obstruction as effectively as exercise testing, as indicated by measurements of changes in the pressure produced by blood as it is pumped out of the left ventricle. ISDN inhalation is therefore equivalent to exercise testing for detecting LVOT obstruction, and can be reliably used in a clinical setting to identify symptomatic HCM patients who cannot perform the exercise test.</p><p></p><h2>Other Information</h2><p>Published in: QScience.com Highlights, Published by Nature Research for Hamad bin Khalifa University Press (HBKU Press)<br>License: <a href="http://creativecommons.org/licenses/by/4.0" target="_blank">http://creativecommons.org/licenses/by/4.0</a><br></p><p><br></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_b638a9bee0aa6e210ff8a77f4bc154f0 |
| identifier_str_mv | 10.57945/manara.23910165.v1 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/23910165 |
| publishDate | 2015 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | New screening method for common heart disorderNature Research (16552612)Biomedical and clinical sciencesCardiovascular medicine and haematologyCardiologyheart disordertreadmill testingHypertrophic cardiomyopathy<p>A team of Egyptian cardiologists has discovered a simple new way of diagnosing the world’s most common genetically transmitted heart disorder and identifying affected patients who have an increased risk of adverse cardiovascular events . Hypertrophic cardiomyopathy (HCM) affects approximately 1 in 500 people and is characterised primarily by abnormal thickening of the heart’s muscle tissue, which makes it harder for the heart to pump blood around the body. One common complication of the condition is obstruction of the left ventricular outflow tract (LVOT), in which the volume of blood pumped around the body is dramatically reduced. LVOT obstruction can occur under stress and during exercise, when contractility of the left ventricle increases. It leads to progression of hypertrophic cardiomyopathy, and predicts adverse outcomes such as cardiac arrest and sudden death in HCM patients. Over 30 percent of patients who have non-obstructive cardiomyopathy do end up with obstruction under stress or exercise. Clinicians can provoke LVOT obstruction in patients by exercise treadmill testing, in order to screen for and diagnose HCM, and to predict future complications, but this is not possible in those who are not able to do exercise for any reason. Hala Mahfouz Badran of Menoufiya University and her colleagues studied 39 HCM patients. They used echocardiography to measure the patients’ heart activity at rest, then compared exercise and an under-the-tongue spray of isosorbide dinitrate (ISDN) — which is used to treat angina — in their ability to induce and evaluate LVOT obstruction. They found that ISDN inhalation provokes LVOT obstruction as effectively as exercise testing, as indicated by measurements of changes in the pressure produced by blood as it is pumped out of the left ventricle. ISDN inhalation is therefore equivalent to exercise testing for detecting LVOT obstruction, and can be reliably used in a clinical setting to identify symptomatic HCM patients who cannot perform the exercise test.</p><p></p><h2>Other Information</h2><p>Published in: QScience.com Highlights, Published by Nature Research for Hamad bin Khalifa University Press (HBKU Press)<br>License: <a href="http://creativecommons.org/licenses/by/4.0" target="_blank">http://creativecommons.org/licenses/by/4.0</a><br></p><p><br></p>2015-04-30T00:00:00ZTextOnline resourceinfo:eu-repo/semantics/publishedVersiontext10.57945/manara.23910165.v1https://figshare.com/articles/online_resource/New_screening_method_for_common_heart_disorder/23910165CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/239101652015-04-30T00:00:00Z |
| spellingShingle | New screening method for common heart disorder Nature Research (16552612) Biomedical and clinical sciences Cardiovascular medicine and haematology Cardiology heart disorder treadmill testing Hypertrophic cardiomyopathy |
| status_str | publishedVersion |
| title | New screening method for common heart disorder |
| title_full | New screening method for common heart disorder |
| title_fullStr | New screening method for common heart disorder |
| title_full_unstemmed | New screening method for common heart disorder |
| title_short | New screening method for common heart disorder |
| title_sort | New screening method for common heart disorder |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Cardiology heart disorder treadmill testing Hypertrophic cardiomyopathy |